A systematic evaluation of miRNA: MRNA interactions involved in the migration and invasion of breast cancer cells

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Luo, Daya ^a,b   Wilson, James M ^b   Harvel, Nikki ^b   Liu, Jimei ^b   Pei, Lirong ^b   Huang, Shuang ^b   Hawthorn, LesleyAnn ^b   Shi, Huidong ^b  

^a NANCHANG UNIVERSITY   (China)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Breast cancer; Invasion; MicroRNA target genes; Migration

Indexed keywords

BIOLOGICAL MARKER; LAMININ GAMMA1; MESSENGER RNA; MICRORNA; MICRORNA 100; MICRORNA 125B1; MICRORNA 138; MICRORNA 141; MICRORNA 146A; MICRORNA 183; MICRORNA 200C; MICRORNA 203; MICRORNA 205; MICRORNA 34A; MICRORNA 375; PROTEIN KINASE C ALPHA; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GRADING; CANCER PROGNOSIS; CANCER TISSUE; CDH11 GENE; CELL INVASION; CELL MIGRATION; CELL STRAIN MDA MB 231; CFL2 GENE; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LAMC1 GENE; LDHB GENE; MIGRATION INHIBITION; NUCLEOTIDE SEQUENCE; PREDICTION; PRKCA GENE; PTPRJ GENE; PTPRM GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEC23A GENE; TIMP2 GENE; TISSUE MICROARRAY; ZEB1 GENE;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84874456193     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-57     Document Type: Article

References (36)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233. 10.1016/j.cell.2009.01.002, 19167326.
2. Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009, 136:586-591. 10.1016/j.cell.2009.02.005, 19239879.
3. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070. 10.1158/0008-5472.CAN-05-1783, 16103053.
4. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007, 131:1109-1123. 10.1016/j.cell.2007.10.054, 18083101.
5. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009, 137:1032-1046. 10.1016/j.cell.2009.03.047, 2766609, 19524507.
6. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449:682-688. 10.1038/nature06174, 17898713.
7. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW, Weinberg RA. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010, 28:341-347. 10.1038/nbt.1618, 2852471, 20351690.
8. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137:1005-1017. 10.1016/j.cell.2009.04.021, 2722880, 19524505.
9. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006, 12:895-904. 10.1038/nm1469, 16892035.
10. Valastyan S, Weinberg RA. Tumor Metastasis: Molecular Insights and Evolving Paradigms. Cell 2011, 147:275-292. 10.1016/j.cell.2011.09.024, 3261217, 22000009.
11. Sreekumar R, Sayan BS, Mirnezami AH, Sayan AE. MicroRNA control of invasion and metastasis pathways. Frontiers Genet 2011, 2:58.
12. Baranwal S, Alahari SK. miRNA control of tumor cell invasion and metastasis. Int J Cancer 2010, 126:1283-1290. 2950784, 19877123.
13. Su S, Li Y, Luo Y, Sheng Y, Su Y, Padia RN, Pan ZK, Dong Z, Huang S. Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration. Oncogene 2009, 28:3047-3057. 10.1038/onc.2009.163, 2733915, 19543320.
14. McCarty KS, Miller LS, Cox EB, Konrath J, McCarty KS. Estrogen receptor analyses, Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 1985, 109:716-721.
15. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008, 10:593-601. 10.1038/ncb1722, 18376396.
16. Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F, Shen Y, Lu W, Wan X, Xie X. miR-375 Is Down-Regulated in Squamous Cervical Cancer and Inhibits Cell Migration and Invasion via Targeting Transcription Factor SP1. Am J Pathol 2011, 179:2580-2588. 10.1016/j.ajpath.2011.07.037, 3204087, 21945323.
17. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe J-P, Tong F. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006, 10:515-527. 10.1016/j.ccr.2006.10.008, 2730521, 17157791.
18. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 2009, 69:1279-1283. 10.1158/0008-5472.CAN-08-3559, 2754225, 19190326.
19. Enerly E, Steinfeld I, Kleivi K, Leivonen S-K, Aure MR, Russnes HG, Ronneberg JA, Johnsen H, Navon R, Rodland E. miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors. PLoS One 2011, 6:e16915. 10.1371/journal.pone.0016915, 3043070, 21364938.
20. Genovesi LA, Carter KW, Gottardo NG, Giles KM, Dallas PB. Integrated Analysis of miRNA and mRNA Expression in Childhood Medulloblastoma Compared with Neural Stem Cells. PLoS One 2011, 6:e23935. 10.1371/journal.pone.0023935, 3170291, 21931624.
21. Havelange V, Stauffer N, Heaphy CCE, Volinia S, Andreeff M, Marcucci G, Croce CM, Garzon R. Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profiling. Cancer 2011, 117:4696-4706. 10.1002/cncr.26096, 3154970, 21455993.
22. Ma L, Huang Y, Zhu W, Zhou S, Zhou J, Zeng F, Liu X, Zhang Y, Yu J. An Integrated Analysis of miRNA and mRNA Expressions in Non-Small Cell Lung Cancers. PLoS One 2011, 6:e26502. 10.1371/journal.pone.0026502, 3203153, 22046296.
23. Qin L-X. An Integrative Analysis of microRNA and mRNA Expression - A Case Study. Cancer Informatics 2008, 6:0.
24. Van der Auwera I, Limame R, van Dam P, Vermeulen PB, Dirix LY, Van Laere SJ. Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype. Br J Cancer 2010, 103:532-541. 10.1038/sj.bjc.6605787, 2939785, 20664596.
25. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 2006, 440:1222-1226. 10.1038/nature04695, 16642001.
26. Chen LC, Tu SH, Huang CS, Chen CS, Ho CT, Lin HW, Lee CH, Chang HW, Chang CH, Wu CH. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway. Breast Cancer Res Treat 2012, 134:989-1004. 10.1007/s10549-012-1986-8, 22434522.
27. Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 2007, 7:55. 10.1186/1471-2407-7-55, 1852112, 17389037.
28. Al-Alwan M, Olabi S, Ghebeh H, Barhoush E, Tulbah A, Al-Tweigeri T, Ajarim D, Adra C. Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules. PLoS One 2011, 6:e27339. 10.1371/journal.pone.0027339, 3208623, 22076152.
29. Li Y, Guo Z, Chen H, Dong Z, Pan ZK, Ding H, Su SB, Huang S. HOXC8-Dependent Cadherin 11 Expression Facilitates Breast Cancer Cell Migration through Trio and Rac. Genes Cancer 2011, 2:880-888. 10.1177/1947601911433129, 3352157, 22593800.
30. Hurteau GJ, Spivack SD, Brock GJ. Potential mRNA Degradation Targets of hsa-miR-200c. Cell Cycle 2006, 5:1951-1956. 10.4161/cc.5.17.3133, 16929162.
31. Lonne G, Cornmark L, Zahirovic I, Landberg G, Jirstrom K, Larsson C. PKCalpha expression is a marker for breast cancer aggressiveness. Mol Cancer 2010, 9:76. 10.1186/1476-4598-9-76, 2873434, 20398285.
32. Yue CH, Chiu YW, Tung JN, Tzang BS, Shiu JJ, Huang WH, Liu JY, Hwang JM. Expression of protein kinase C alpha and the MZF-1 and Elk-1 transcription factors in human breast cancer cells. Chin J Physiol 2012, 55:31-36.
33. Chen RS, Song YM, Zhou ZY, Tong T, Li Y, Fu M, Guo XL, Dong LJ, He X, Qiao HX. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/[beta]-catenin pathway. Oncogene 2008, 28:599-609.
34. Gregory PA, Bracken CP, Smith E, Bert AG, Wright JA, Roslan S, Morris M, Wyatt L, Farshid G, Lim Y-Y. An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell 2011, 22:1686-1698. 10.1091/mbc.E11-02-0103, 3093321, 21411626.
35. Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celia-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nature medicine 2011, 17:1101-1108. 10.1038/nm.2401, 3169707, 21822286.
36. Bernstein BW, Bamburg JR. ADF/Cofilin: a functional node in cell biology. Trends Cell Biol 2010, 20:187-195. 10.1016/j.tcb.2010.01.001, 2849908, 20133134.